相关实验视频
Updated: Jul 23, 2025

04:25
A Mice Model of Chlorhexidine Gluconate-Induced Peritoneal Damage
Published on: April 28, 2022
1.9K
赫西丁对肝脏代谢的有害影响
Heloisa V Pereira-Maróstica1, Ana Paula Ames-Sibin1, Vanesa de O Pateis1
1Department of Biochemistry, State University of Maringá, Maringá, PR, Brazil.
Environmental toxicology and pharmacology
|July 13, 2023
概括
赫西丁 (CHX) 是一种常见的消毒剂,通过抑制葡萄糖合成和尿素循环来破坏肝脏的能量代谢. 这可能会导致严重的健康问题,如低血糖症和乳酸化症.
科学领域:
- 生物化学 生物化学
- 毒理学 毒理学 毒理学
- 细胞生物学 细胞生物学
背景情况:
- 赫西丁 (CHX) 是一种广泛使用的消毒剂.
- 以前的报道表明,CHX作为解器和抑制剂影响线粒体功能.
研究的目的:
- 研究CHX对与能量代谢相关的肝脏代谢途径的短期影响.
- 为了评估CHX对 perfused大鼠肝脏的影响.
主要方法:
- 使用过的老鼠肝脏模型.
- 研究了对葡萄糖合成,尿素循环,氧气消耗和细胞ATP含量的影响.
- 研究了孤立的线粒体对CHX的反应.
主要成果:
- CHX抑制了葡萄糖合成和尿素循环.
- 氧气消耗在低度CHX时增加,在高度时减少.
- 细胞ATP含量减少,糖解刺激,酶泄漏 (LDH,烟酶) 增加.
- 在孤立的线粒体中,CHX抑制了pyruvate的碳化,氧化和氧吸收,同时促进了解.
结论:
- CHX显著破坏肝脏能量代谢.
- 观察到的效应引发了对潜在的低血糖,乳酸,氨血和细胞膜损伤的安全担忧.
更多相关视频
相关概念视频
Hepatic Drug Clearance: Effect of Protein Binding
249
Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
249
Hepatic Drug Excretion: Enterohepatic Cycling
1.6K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
1.6K
Hepatic Drug Excretion: Influencing Factors
158
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
158
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
206
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
206
Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance
148
Hepatic clearance refers to the volume of blood cleared of a drug by the liver per unit of time. It plays a crucial role in drug metabolism and elimination. While hepatic clearance is commonly estimated by subtracting renal clearance from total body clearance, other pathways, such as pulmonary or biliary clearance, may also contribute. However, these pathways are generally less significant than hepatic and renal clearance.
Most drugs undergo restrictive clearance, which is proportional to the...
Most drugs undergo restrictive clearance, which is proportional to the...
148
Factors Influencing Drug Absorption: Disease States and Pharmacology
586
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
586

